The U.N. General Assembly has voted overwhelmingly to approve a 40-member global scientific panel on the impacts and risks of ...
(PRESS RELEASE) BASEL, 13-Feb-2026 — / EuropaWire / — Novartis has announced final Phase III results from the ALIGN study evaluating Vanrafia (atrasentan) in adults with IgA nephropathy (IgAN), ...